BRIEF-Amathus Therapeutics Signs Strategic Collaboration With Merck To Develop Treatments For Neurodegenerative Diseases

Reuters · 03/17/2021 12:07
BRIEF-Amathus Therapeutics Signs Strategic Collaboration With Merck To Develop Treatments For Neurodegenerative Diseases

- Merck & Co Inc MRK.N:

  • AMATHUS THERAPEUTICS SIGNS STRATEGIC COLLABORATION WITH MERCK TO DEVELOP TREATMENTS FOR NEURODEGENERATIVE DISEASES

Source text for Eikon: ID:nBw3vYJw0a

Further company coverage: MRK.N


((Reuters.Briefs@thomsonreuters.com;))